Cholinergic lesions produce task-selective effects on delayed matching to position and configural association

R B Gibbs1, D A Johnson

  • 1Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, 1004 Salk Hall, Pittsburgh, PA 15261, USA. gibbsr@pitt.edu <gibbsr@pitt.edu>

Insights

Selective basal forebrain cholinergic lesions impair learning in rats, affecting task-specific strategies rather than working memory. These findings highlight the role of cholinergic systems in cognitive flexibility and attention.

Area of Science:

  • Neuroscience
  • Cognitive Neuroscience
  • Behavioral Neuroscience

Background:

  • Cholinergic neurons in the basal forebrain are crucial for learning and memory.
  • Selective lesions can elucidate the specific roles of these neurons in different cognitive functions.

Purpose of the Study:

  • To investigate the effects of selective basal forebrain cholinergic lesions on two distinct cognitive tasks.
  • To compare the impact of lesions in rostral versus caudal basal forebrain on learning and strategy use.

Main Methods:

  • Ovariectomized rats received infusions of 192IgG-saporin (SAP) to selectively lesion cholinergic neurons in the medial septum (MS) and/or nucleus basalis magnocellularis (NBM).
  • Lesioned rats were tested on a delayed matching to position (DMP) T-maze task and a configural association (CA) operant conditioning task.
  • Performance was assessed based on acquisition, working memory, response patterns, strategy use, and response time.

Main Results:

  • SAP lesions in MS or NBM significantly impaired DMP task acquisition, primarily affecting response patterns, not working memory.
  • Lesions did not correlate with hippocampal cholinergic denervation but influenced strategy use (allocentric vs. egocentric).
  • SAP-NBM lesions caused minor impairments in CA task acquisition (response time, number of responses), suggesting effects on attention/alertness.

Conclusions:

  • Selective basal forebrain cholinergic lesions induce task-specific learning deficits.
  • Cholinergic denervation impacts learning strategies and patterns without necessarily impairing working memory.
  • These findings underscore the role of basal forebrain cholinergic systems in cognitive flexibility and attention.

Related Concept Videos

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
Direct-Acting Cholinergic Agonists: Pharmacokinetics01:31

Direct-Acting Cholinergic Agonists: Pharmacokinetics

Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Indirect-Acting Cholinergic Agonists: Pharmacokinetics01:22

Indirect-Acting Cholinergic Agonists: Pharmacokinetics

Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...